Fitzsimmons–Guilbert syndrome
Fitzsimmons–Guilbert syndrome is a rare genetic disorder characterized by a combination of distinctive physical and developmental features. The syndrome is named after the researchers who first identified and described the condition.
Presentation[edit | edit source]
Individuals with Fitzsimmons–Guilbert syndrome typically present with a range of symptoms that may include intellectual disability, developmental delay, and distinctive facial features. Common physical characteristics may include microcephaly (a smaller than average head size), epicanthal folds (skin folds of the upper eyelid covering the inner corner of the eye), and low-set ears. Other possible features include congenital heart defects, skeletal abnormalities, and growth retardation.
Genetics[edit | edit source]
Fitzsimmons–Guilbert syndrome is believed to be inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in Fitzsimmons–Guilbert syndrome have not yet been identified, and research is ongoing to determine the genetic basis of the condition.
Diagnosis[edit | edit source]
Diagnosis of Fitzsimmons–Guilbert syndrome is typically based on clinical evaluation and the presence of characteristic physical and developmental features. Genetic testing may be used to confirm the diagnosis and to identify the specific genetic mutation responsible for the condition. Prenatal diagnosis may be possible if the genetic mutation is known in the family.
Management[edit | edit source]
There is currently no cure for Fitzsimmons–Guilbert syndrome, and treatment is primarily supportive and symptomatic. Management may involve a multidisciplinary approach, including pediatricians, geneticists, cardiologists, and other specialists as needed. Early intervention programs, including physical therapy, occupational therapy, and speech therapy, may help improve developmental outcomes for affected individuals.
Prognosis[edit | edit source]
The prognosis for individuals with Fitzsimmons–Guilbert syndrome varies depending on the severity of the symptoms and the presence of any associated health issues. With appropriate medical care and supportive therapies, some individuals may achieve a good quality of life, while others may have more significant challenges.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD